Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Pb Multiple | 0.5x - 0.6x | 0.5x |
| Historical Pb Multiple | 0.4x - 0.8x | 0.6x |
| Fair Value | ₩10,284 - ₩11,367 | ₩10,826 |
| Upside | 30.3% - 44.1% | 37.2% |
| Benchmarks | - | Full Ticker |
| Theragen Etex Co.,Ltd. | - | KOSDAQ:A066700 |
| JETEMA, Co., Ltd. | - | KOSDAQ:A216080 |
| Aprogen Biologics Inc. | - | KOSE:A003060 |
| CMG Pharmaceutical Co., Ltd. | - | KOSDAQ:A058820 |
| KOREA PHARMA Co., Ltd. | - | KOSDAQ:A032300 |
| Jeil Pharma Holdings Inc | - | KOSE:A002620 |
| Select Price / Book Ratio | ||||||||
| Benchmark Companies | ||||||||
| A066700 | A216080 | A003060 | A058820 | A032300 | A002620 | |||
| KOSDAQ:A066700 | KOSDAQ:A216080 | KOSE:A003060 | KOSDAQ:A058820 | KOSDAQ:A032300 | KOSE:A002620 | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | NM- | NM- | NM- | -2.5% | -7.3% | NM- | ||
| 3Y CAGR | NM- | NM- | NM- | NM- | -15.9% | NM- | ||
| Latest Twelve Months | -252.2% | -101.3% | 11.2% | -58.3% | 4426.7% | -214.8% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 5.0% | 4.0% | -28.1% | 4.7% | 3.3% | -5.2% | ||
| Prior Fiscal Year | 12.7% | 23.8% | -135.4% | 6.9% | 0.1% | -2.0% | ||
| Latest Fiscal Year | -16.8% | -0.3% | -155.8% | 2.7% | 4.7% | -6.6% | ||
| Latest Twelve Months | -16.8% | -0.3% | -155.8% | 2.7% | 4.7% | -6.6% | ||
| Return on Equity | ||||||||
| 5 Year Average Margin | 6.0% | 3.6% | -6.6% | 1.6% | 5.5% | -9.0% | ||
| Prior Fiscal Year | 19.7% | 21.7% | -29.7% | 3.4% | 0.1% | -4.9% | ||
| Latest Twelve Months | -33.8% | -0.3% | -28.1% | 1.4% | 5.4% | -16.3% | ||
| Next Fiscal Year | -106.3% | 10.5% | #NUM! | 3.1% | 5.1% | -4.2% | ||
| Two Fiscal Years Forward | 723.8% | 30.6% | -32.2% | 3.1% | 4.9% | -4.4% | ||
| Current Trading Multiples | ||||||||
| Price / LTM Sales | 0.4x | 3.9x | 3.3x | 2.9x | 1.9x | 0.2x | ||
| Price / LTM EPS | -2.3x | -1412.8x | -2.1x | 108.0x | 40.6x | -2.4x | ||
| Price / Book | 0.8x | 3.7x | 0.6x | 1.5x | 2.2x | 0.4x | ||
| Price / Fwd Book | 2.8x | 3.3x | 0.6x | 1.5x | 2.1x | 0.4x | ||
| Low | Mid | High | ||||||
| Benchmark P/B Ratio | 0.6x | 1.5x | 3.7x | |||||
| Historical P/B Ratio | 0.4x | 0.6x | 0.8x | |||||
| Selected P/B Multiple | 0.5x | 0.5x | 0.6x | |||||
| (x) Book Value | 306,950 | 306,950 | 306,950 | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | A066700 | A216080 | A003060 | A058820 | A032300 | A002620 | |
| Value of Common Equity | 94,896 | 265,966 | 219,249 | 290,979 | 153,784 | 121,120 | |
| (/) Shares Outstanding | 32.0 | 35.8 | 311.0 | 138.9 | 10.9 | 15.4 | |
| Implied Stock Price | 2,965.00 | 7,420.00 | 705.00 | 2,095.00 | 14,100.00 | 7,890.00 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 2,965.00 | 7,420.00 | 705.00 | 2,095.00 | 14,100.00 | 7,890.00 | |
| Trading Currency | KRW | KRW | KRW | KRW | KRW | KRW | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |